K183383 is an FDA 510(k) clearance for the ANAX? OCT Spinal System. This device is classified as a Posterior Cervical Screw System (Class II - Special Controls, product code NKG).
Submitted by U&I Corporation (Uijeongbu-Si, KR). The FDA issued a Cleared decision on December 12, 2018, 6 days after receiving the submission on December 6, 2018.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3075. Posterior Cervical Screw Systems Are Intended For Use In Fusion Procedures Of The Cervical Spine And/or Craniocervical Junction And/or Cervicothoracic Junction For: 1) Spinal Fractures And Dislocations; 2) Deformities; 3) Instabilities; 4) Failed Previous Fusions; 5) Tumors; 6) Inflammatory Disorders; 7) Spinal Degeneration, 8) Facet Degeneration With Instability; And 9) Reconstruction Following Decompression To Treat Radiculopathy And/or Myelopathy. These Systems Are Also Intended To Stabilize The Spine In The Absence Of Fusion For A Limited Time Period In Patients With Tumors Involving The Cervical Spine In Whom Life Expectancy Is Of Insufficient Duration To Permit Achievement Of Fusion..